Federal Register / Vol. 65, No. 24 / Friday, February 4, 2000 / Notices 5649

applicants representing all types of

communities. Applicants who receive

funding may be large health care

systems or small organizations.

Applications are encouraged from large

urban areas, small rural communities,

and tribal organizations.

Applications may be submitted by

public, private, and non-profit entities

that demonstrate a commitment to and

experience with providing a continuum

of care to uninsured individuals. Each

applicant must represent a communitywide coalition that is committed to the

project and includes safety net

providers (where they exist) who have

traditionally provided care to the

community’s uninsured and

underinsured regardless of ability to

pay. The community-wide coalition

must consist of partners from all levels

of care (i.e., primary, secondary,

tertiary) and partners who represent a

range of services (e.g., mental health and

substance abuse treatment, maternal and

child health care, oral health, HIV/

AIDS).

Examples of eligible applicants who

may apply on behalf of the communitywide coalition include but are not

limited to:

• A consortium or network of

providers (e.g., public and charitable

hospitals; community, migrant,

homeless, public housing, and schoolbased health centers; rural health

clinics; free health clinics; teaching

hospitals and health professions

education schools)

• Local government agencies (e.g.,

local public health departments with

service delivery components)

• Tribal governments

• Managed care plans or other payers

(e.g., HMOs, insurance companies)

Agencies of State governments, multistate health systems, or special interest

groups may submit applications on

behalf of multiple communities if they

demonstrate the ability to coordinate

community health care delivery systems

and bring resources to the community.

Competing applications for the same

patient population will not be

considered for funding; therefore,

applicants from the same community

are required to collaborate.

Funding Criteria

• Review criteria that will be used to

evaluate applications include:

• Evidence of progress towards

integration prior to application for

funding

• Evidence that the target population

has a high or increasing rate of

uninsurance

• Evidence of established

partnerships among a broad-based

community consortium

• Appropriateness and quality of

clinical services to be provided

• Commitments from local

government agencies, public and private

health care providers, community

leaders

• Demonstration of existing and

sustainable public and private funding

sources

• Accountable management and

budget plan

• Commitment to self evaluation and

participation in a national evaluation

Program Expectations

Funding through this initiative may

be used to support a variety of projects

that would improve access to all levels

of care for the uninsured and

underinsured. While each community

should design a program that best

addresses the needs of the uninsured

and underinsured, and the providers in

their community, funding is intended to

encourage safety net providers to

develop coordinated care systems for

the community’s uninsured and

underinsured.

Examples of activities that could be

supported with this funding include:

• Offering a comprehensive delivery

system for the uninsured and

underinsured through a network of

safety net providers. [Single registration,

eligibility systems]

• Integrating preventive, mental

health, substance abuse, HIV/AIDS, and

maternal and child health services

within the system. [Block grant funded

services, other DHHS programs, state

and local programs]

• Developing a shared information

system among the community’s safety

net providers. [Tracking, case

management, medical records, financial

records]

• Developing and incorporating

shared clinical protocols, quality

improvement systems, utilization

management systems, and error

prevention systems.

• Sharing core management

functions. [Finance, purchasing,

appointment systems]

• Coordinating and strengthening

priority services to specific targeted

patient groups.

• Developing affordable

pharmaceutical services.

Use of Grant Funds

Funding provided through this

program may NOT be used to substitute

for or duplicate funds currently

supporting similar activities. Grant

funds may support costs such as:

• Project staff salaries

• Consultant support

• Management information systems

(e.g., hardware and software)

• Project-related travel

• Other direct expenses necessary for

the integration of administrative,

clinical, information system, or

financial functions

• Program evaluation activities

With appropriate justification on why

funds are needed to support the

following costs, up to 15 percent of

grant funds may be used for:

• Alteration or renovation of facilities

• Primary care site development

• Service expansions or direct patient

care

Grant funds may NOT be used for:

• Construction

• Reserve requirements for state

insurance licensure

Expected Results

The integration and coordination of

services among a community’s safety

net providers are expected to result in:

• A system of care that provides

coordinated coverage to the target

population.

• Increased access to primary care

resulting in a reduction in hospital

admissions for ambulatory sensitive

conditions among the uninsured and

underinsured.

• Elimination of unnecessary,

duplicate functions in service delivery

and administrative functions, resulting

in savings to reinvest in the system.

• Increased numbers of low-income

uninsured people with access to a full

range of health services.

Dated: January 31, 2000.

Claude Earl Fox,

Administrator.

[FR Doc. 00–2567 Filed 2–3–00; 8:45 am]

BILLING CODE 4160–15–U

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Resources and Services

Administration

Advisory Council; Notice of Meeting;

Correction

In Federal Register Document 00–

1032 appearing on page 2634 in the

issue for Tuesday, January 18, 2000, the

February 10–11, 2000, meeting dates of

the ‘‘National Advisory Council on

Migrant Health’’ are incorrect. The

meeting will be held on February 11–12,

2000; 9:00 a.m.–5:00 p.m.

All other information is correct as it

appears.

5650 Federal Register / Vol. 65, No. 24 / Friday, February 4, 2000 / Notices

Dated: January 28, 2000.

Jane M. Harrison,

Director, Division of Policy Review and

Coordination.

[FR Doc. 00–2434 Filed 2–3–00; 8:45 am]

BILLING CODE 4160–15–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Substance Abuse and Mental Health

Services Administration

Current List of Laboratories Which

Meet Minimum Standards To Engage in

Urine Drug Testing for Federal

Agencies, and Laboratories That Have

Withdrawn From the Program

AGENCY: Substance Abuse and Mental

Health Services Administration, HHS.

ACTION: Notice.

SUMMARY: The Department of Health and

Human Services notifies Federal

agencies of the laboratories currently

certified to meet standards of Subpart C

of Mandatory Guidelines for Federal

Workplace Drug Testing Programs (59

FR 29916, 29925). A similar notice

listing all currently certified laboratories

will be published during the first week

of each month, and updated to include

laboratories which subsequently apply

for and complete the certification

process. If any listed laboratory’s

certification is totally suspended or

revoked, the laboratory will be omitted

from updated lists until such time as it

is restored to full certification under the

Guidelines.

If any laboratory has withdrawn from

the National Laboratory Certification

Program during the past month, it will

be listed at the end, and will be omitted

from the monthly listing thereafter.

This Notice is available on the

internet at the following website: http:/

/wmcare.samhsa.gov

FOR FURTHER INFORMATION CONTACT: Mrs.

Giselle Hersh or Dr. Walter Vogl,

Division of Workplace Programs, 5600

Fishers Lane, Rockwall 2 Building,

Room 815, Rockville, Maryland 20857;

Tel.: (301) 443–6014, Fax: (301) 443–

3031.

SPECIAL NOTE: Please use the above

address for all surface mail and

correspondence. For all overnight mail

service use the following address:

Division of Workplace Programs, 5515

Security Lane, Room 815, Rockville,

Maryland 20852.

SUPPLEMENTARY INFORMATION:

Mandatory Guidelines for Federal

Workplace Drug Testing were developed

in accordance with Executive Order

12564 and section 503 of Pub. L. 100–

71. Subpart C of the Guidelines,

‘‘Certification of Laboratories Engaged

in Urine Drug Testing for Federal

Agencies,’’ sets strict standards which

laboratories must meet in order to

conduct urine drug testing for Federal

agencies. To become certified an

applicant laboratory must undergo three

rounds of performance testing plus an

on-site inspection. To maintain that

certification a laboratory must

participate in a quarterly performance

testing program plus periodic, on-site

inspections.

Laboratories which claim to be in the

applicant stage of certification are not to

be considered as meeting the minimum

requirements expressed in the HHS

Guidelines. A laboratory must have its

letter of certification from SAMHSA,

HHS (formerly: HHS/NIDA) which

attests that it has met minimum

standards.

In accordance with Subpart C of the

Guidelines, the following laboratories

meet the minimum standards set forth

in the Guidelines:

ACL Laboratories,8901 W. Lincoln Ave.,West

Allis, WI 53227,414–328–7840/800–877–

7016,(Formerly: Bayshore Clinical

Laboratory).

Advanced Toxicology Network,3560 Air

Center Cove, Suite 101,Memphis, TN

38118,901–794–5770/888–290–1150.

Aegis Analytical Laboratories, Inc.,345 Hill

Ave.,Nashville, TN 37210,615–255–2400.

Alabama Reference Laboratories, Inc.,543

South Hull St.,Montgomery, AL

36103,800–541–4931/334–263–5745.

Alliance Laboratory Services,3200 Burnet

Ave.,Cincinnati, OH 45229,513–585–

9000,(Formerly: Jewish Hospital of

Cincinnati, Inc.).

American Medical Laboratories, Inc.,14225

Newbrook Dr.,Chantilly, VA 20151,703–

802–6900.

Associated Pathologists Laboratories,

Inc.,4230 South Burnham Ave., Suite

250,Las Vegas, NV 89119–5412,702–733–

7866/800–433–2750.

Baptist Medical Center—Toxicology

Laboratory,9601 I–630, Exit 7,Little Rock,

AR 72205–7299,501–202–2783,(Formerly:

Forensic Toxicology Laboratory Baptist

Medical Center).

Clinical Reference Lab,8433 Quivira

Rd.,Lenexa, KS 66215–2802800–445–6917.

Cox Health Systems, Department of

Toxicology,1423 North Jefferson

Ave.,Springfield, MO 65802,800–876–

3652/417–269–3093,(Formerly: Cox

Medical Centers).

Dept. of the Navy, Navy Drug Screening

Laboratory,Great Lakes, IL,P.O. Box 88–

6819,Great Lakes, IL 60088–6819,847–688–

2045/847–688–4171.

Diagnostic Services Inc., dba DSI,12700

Westlinks Drive,Fort Myers, FL 33913,941–

561–8200/800–735–5416.

Doctors Laboratory, Inc.,P.O. Box 2658,2906

Julia Dr.,Valdosta, GA 31604,912–244–

4468.

DrugProof, Division of Dynacare/Laboratory

of Pathology, LLC,1229 Madison St., Suite

500, Nordstrom Medical Tower,Seattle,

WA 98104,206–386–2672/800–898–

0180,(Formerly: Laboratory of Pathology of

Seattle, Inc., DrugProof,Division of

Laboratory of Pathology of Seattle, Inc.).

DrugScan, Inc.,P.O. Box 2969,1119 Mearns

Rd.,Warminster, PA 18974,215–674–9310.

Dynacare Kasper Medical

Laboratories*,14940–123 Ave.,Edmonton,

Alberta,Canada T5V 1B4,780–451–3702/

800–661–9876.

ElSohly Laboratories, Inc.,5 Industrial Park

Dr.,Oxford, MS 38655,601–236–2609.

Gamma-Dynacare Medical Laboratories*,A

Division of the Gamma-Dynacare

Laboratory Partnership,245 Pall Mall

St.,London, ON,Canada N6A 1P4,519–679–

1630.

General Medical Laboratories,36 South

Brooks St.,Madison, WI 53715,608–267–

6267.

Hartford Hospital Toxicology Laboratory,80

Seymour St.,Hartford, CT 06102–5037,860–

545–6023.

Info-Meth,112 Crescent Ave.,Peoria, IL

61636,309–671–5199/800–752–

1835,(Formerly: Methodist Medical Center

Toxicology Laboratory).

Integrated Regional Laboratories,5631 NW

33rd Avenue,Fort Lauderdale, FL

33309,954–777–0018, 800–522–

0232,(Formerly: Cedars Medical Center,

Department of Pathology).

Kroll Laboratory Specialists, Inc.,1111

Newton St.,Gretna, LA 70053,504–361–

8989/800–433–3823,(Formerly: Laboratory

Specialists, Inc.).

Laboratory Corporation of America

Holdings,1904 Alexander Drive,Research

Triangle Park, NC 27709,919–572–6900/

800–833–3984,(Formerly: LabCorp

Occupational Testing Services, Inc.,

CompuChem Laboratories, Inc.;

CompuChem Laboratories, Inc., A

Subsidiary of Roche Biomedical

Laboratory; Roche CompuChem

Laboratories, Inc., A Member of the Roche

Group).

Laboratory Corporation of America

Holdings,4022 Willow Lake

Blvd.,Memphis, TN 38118,901–795–1515/

800–233–6339,(Formerly: LabCorp

Occupational Testing Services,

Inc.,MedExpress/National Laboratory

Center).

LabOne, Inc.,10101 Renner Blvd.,Lenexa, KS

66219,913–888–3927/800–728–

4064,(Formerly: Center for Laboratory

Services, a Division of LabOne, Inc.)

Laboratory Corporation of America

Holdings,69 First Ave.,Raritan, NJ

08869,908–526–2400/800–437–

4986,(Formerly: Roche Biomedical

Laboratories, Inc.)

Marshfield Laboratories,Forensic Toxicology

Laboratory,1000 North Oak

Ave.,Marshfield, WI 54449,715–389–3734/

800–331–3734

MAXXAM Analytics Inc.*,5540 McAdam

Rd.,Mississauga, ON,Canada L4Z 1P1,905–

890–2555,(Formerly: NOVAMANN

(Ontario) Inc.)

Medical College Hospitals Toxicology

Laboratory,Department of Pathology,3000